Institution
Centre Hospitalier Universitaire de Liège
Recent research
- Health & MedicineOpen access
Immune‐related adverse events with mogamulizumab in cutaneous T‐cell lymphoma: A multicentre study
BACKGROUND: Mogamulizumab, an anti-CCR4 monoclonal antibody used in advanced mycosis fungoides (MF) and Sezary syndrome (SS), also depletes regulatory T cells, potentially leading to immune-related adverse events (irAEs). Unlike mogamulizumab-associated rash (MAR), other irAEs re...
- Health & Medicine
Maria Fusaro, Pasquale Perrone Filardi, Gianfranco Sinagra, Maria Luisa Brandi, Maurizio Gallieni, Jean-Yves Reginster, Eugene McCloskey, Etienne Cavalier,
- Health & MedicineOpen access
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly used for the treatment of type 2 diabetes and obesity, but their effects on musculoskeletal health remain completely misunderstood. This systematic review/meta-analysis aims to synthesise clinical data on the...
- Health & MedicineOpen access
Chronic kidney disease (CKD) and cancer are among the most prevalent chronic conditions that increasingly demand reliable long-term central venous access devices (CVADs), including central venous catheters (CVCs), peripherally inserted central catheters (PICCs), and implantable p...
- Health & Medicine
BIOCOST: A Costing Tool for Belgian Biobanks
BACKGROUND: Biobanks are essential infrastructures for biomedical research, yet their long-term sustainability is increasingly challenged by complex and often underestimated costs. While numerous cost-accounting approaches have been proposed over the past decade, comparable empir...
- BiologyOpen access
Intellectual disability (ID) and global developmental delay (GDD) are clinically and genetically heterogeneous conditions characterized by impairments in cognitive, motor, and behavioral functions. Despite advances in genomic medicine, individuals of African ancestry remain signi...
- Health & Medicine
Plain Language SummaryWhat is this summary about?This summary describes how well talquetamab worked and its safety at a median (midpoint) of 17–26 months follow-up from the MonumenTAL-1 study, which tested talquetamab treatment for a type of cancer called relapsed/refractory mult...
- Health & MedicineOpen access
Cognitive Fitness in Ageing (COFITAGE): A Multimodal and Longitudinal Neuroimaging Dataset
Purpose: Brain aging involves interrelated changes in molecular processes, neuroinflammatory mechanisms, brain macro- and microstructure, sleep physiology, and cognition. The 50 to 70 years age range represents a critical transition period, in which these subtle alterations may p...
- Society & EconomicsOpen access
Background: Bereavement due to fatal family violence (e.g. intimate partner homicide, filicide, parricide, siblicide) is a profoundly disruptive experience for children, with lifelong psychosocial consequences. Although the need for fatal family violence prevention is increasingl...
- Health & MedicineOpen access
Background and Clinical Significance: Steroid cell tumours of the ovary, not otherwise specified (SCT-NOSs), are rare sex cord–stromal neoplasms with a poorly characterised molecular landscape, in which only exceptional CTNNB1 mutations have so far been reported and no recurrent...